Import and Export of Medical Devices: Regulation 3 and Regulation 4 in South Africa

1. Key takeaways

South Africa has two dedicated provisions governing the cross-border movement of medical devices: Regulation 3 governs the importation of medical devices and IVDs into the Republic of South Africa, and Regulation 4 governs medical devices or IVDs in transit through South Africa. Combined with SAHPRA’s official requirements, any importer must hold a valid establishment licence before commencing business, and no medical device (including IVDs) may be imported without SAHPRA authorisation. The substantive gate at customs clearance is the establishment licence, not a product registration certificate — as at the verification date, no product registration number exists in South Africa.

2. Legal basis

3. Expert insights

Insight 1: The separate listing of Regulation 3 and Regulation 4 shows that importation and transit are two different legal statuses. Importation means the device enters the South African market for circulation; transit merely uses South Africa as a corridor. The two differ in documentation and regulatory intensity, so companies must first determine which category their goods flow belongs to when planning regional logistics — declaring transit goods as imports, or the reverse, will generate compliance problems at the border and potentially downstream in the supply chain. The distinction also affects insurance, liability and after-sales obligations, which attach only once the device has entered the market.

Insight 2: The hard gate at customs clearance is the establishment licence, not a product registration certificate. SAHPRA is explicit: no importation without a valid establishment licence. And because product registration has not yet been called up, no South African registration number exists at the clearance stage. Freight forwarders and customs brokers who demand a South African registration certificate out of habit from other markets are misreading the system, and shippers should brief them before the first consignment rather than at the border. Preparing a standard clearance pack around the establishment licence, and reusing it for every entry, removes this friction.

Insight 3: Veterinary devices equally require authorisation for import. MD05-2025/2026 states clearly: no veterinary medical device (including IVDs) may be imported into South Africa without SAHPRA authorisation. This confirms that devices for animal use are equally bound by the device framework, and no exception may be assumed at the import or export stage merely because the product is not destined for human patients. Veterinary product lines should therefore be mapped into the same import planning process as human devices.

Insight 4: Import capability follows directly from the licence type. Among the official licence categories, the distributor licence covers import and export, and the manufacturer licence also covers import and export. A pure wholesaler licence (storage, transport, distribution) does not include import or export authorisation — this must be checked when signing supply agreements, because a correctly typed but under-scoped licence will strand goods at customs. Where a group operates several licensed entities, each entity’s licence must be checked separately against the activities it actually performs.

Insight 5: The reliance pathway also extends to import scenarios. SAHPGL-MD-22 lists imports for donation, exhibition and evaluation purposes among the regulatory activities to which reliance may apply. Practical estimate: imports of devices for exhibition, evaluation or donation can be simplified in combination with the reliance pathway, but the applicable approach must still be confirmed with SAHPRA in advance rather than assumed at the point of entry. Documenting the purpose of each consignment ahead of shipment will speed up that confirmation.

4. Practical recommendations

1. First distinguish importation from transit: determine whether Regulation 3 or Regulation 4 applies.
2. Confirm that the establishment licence includes import or export authorisation: a pure wholesaler licence does not.
3. Build clearance documentation around the establishment licence: never present a non-existent South African registration certificate.
4. Prepare veterinary devices to the same standard: MD05-2025/2026.
5. Confirm with SAHPRA in advance for exhibition, donation and evaluation imports.
6. Brief customs brokers with a unified position: avoid demands for documents based on other markets’ practice.

5. Verification checklist

• □ Goods flow determined as importation (Regulation 3) or transit (Regulation 4)
• □ Establishment licence confirmed to include import or export authorisation
• □ Clearance documentation prepared around a valid establishment licence
• □ Confirmed that no South African product registration number exists as a clearance document
• □ Veterinary devices prepared to the same standard under MD05-2025/2026
• □ Exhibition, donation and evaluation imports confirmed with SAHPRA in advance
• □ Customs brokers and freight forwarders briefed on the South African position
• □ Import and export records archived and available for later inspection cross-checks

Regulatory information verified as at 29 October 2026. The regulations, guidance and effective dates described in this article are limited to the content published by the official sources listed under Legal basis as at that date; where official documents have been updated, the latest published version prevails.

• South Africa local resource: GRZAN can assist manufacturers from the Chinese mainland and overseas in engaging the South African Health Products Regulatory Authority (SAHPRA) on medical device establishment licence (MDEL) applications and product registration preparation, including authorised representative (AR) scheme design, ISO 13485 certification route planning and CAB selection, GMDN coding and classification determination, technical documentation preparation, and the establishment of vigilance and adverse event reporting mechanisms.
• Service capabilities: product attribute determination and risk classification (Class A/B/C/D), establishment licence application and renewal, reliance pathway justification, technical documentation and essential principles conformity argumentation, labelling and instructions-for-use localisation in English, and post-market vigilance and annual compliance information submission support.
• Contact: hito.lin@grzan.cn; website www.grzan.cn.